Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 36

1.

Epilepsy management in older people: Lessons from National Audit of Seizure management in Hospitals (NASH).

Ziso B, Dixon PA, Marson AG.

Seizure. 2017 Aug;50:33-37. doi: 10.1016/j.seizure.2017.05.002. Epub 2017 May 30.

2.

National Audit of Seizure management in Hospitals (NASH): results of the national audit of adult epilepsy in the UK.

Dixon PA, Kirkham JJ, Marson AG, Pearson MG.

BMJ Open. 2015 Mar 31;5(3):e007325. doi: 10.1136/bmjopen-2014-007325.

3.

Episodic fluctuations in larval supply

Dixon PA, Milicich MJ, Sugihara G.

Science. 1999 Mar 5;283(5407):1528-30.

4.

Relationship between plasma and saliva quinine levels in humans.

Babalola CP, Bolaji OO, Ogunbona FA, Dixon PA.

Ther Drug Monit. 1996 Feb;18(1):30-3.

PMID:
8848817
5.

Column liquid chromatographic analysis of quinine in human plasma, saliva and urine.

Babalola CP, Bolaji OO, Dixon PA, Ogunbona FA.

J Chromatogr. 1993 Jun 23;616(1):151-4.

PMID:
8376486
6.

Disposition of quinine in rats with induced renal failure.

Onyeji CO, Dixon PA, Ugwu NC.

Pharm Weekbl Sci. 1992 Aug 21;14(4):185-90.

PMID:
1437497
7.

An in-vitro study of chloroquine transport in the rat submaxillary gland.

Onyeji CO, Dixon PA, Ogunbona FA.

J Pharm Pharmacol. 1992 Feb;44(2):136-8.

PMID:
1352817
8.

Characterization of the principal metabolite of quinine in human urine by 1H-n.m.r. spectroscopy.

Bolaji OO, Babalola CP, Dixon PA.

Xenobiotica. 1991 Apr;21(4):447-50.

PMID:
1897244
9.

Excretion of proguanil in human saliva.

Onyeji CO, Ogunbona FA, Dixon PA.

J Pharm Pharmacol. 1989 Dec;41(12):872-3.

PMID:
2576454
10.
11.

The effect of some hepatotoxins on the sulphoxidation of cimetidine in rat.

Dixon PA, Udeagha AU.

Comp Biochem Physiol C. 1986;83(2):385-6.

PMID:
2872002
12.

Influence of species and drug pretreatment on the metabolic oxidation of cimetidine and metiamide.

Dixon PA, Okereke NO, Ogundahunsi A.

Biochem Pharmacol. 1985 Jun 1;34(11):2028-30. No abstract available.

PMID:
3924053
13.

Influence of species, sex and drug pretreatment on the metabolism of metyrapone.

Dixon PA, Okereke SE, Enwelum MC.

Comp Biochem Physiol C. 1985;81(1):241-3.

PMID:
2861055
14.

A possible cytochrome P-450-mediated N-oxidation of diethylcarbamazine.

Joseph CA, Dixon PA.

J Pharm Pharmacol. 1984 Oct;36(10):711-2.

PMID:
6150098
15.

The spatial distribution of fungi on decomposing alder leaves in a freshwater stream.

Chamier AC, Dixon PA, Archer SA.

Oecologia. 1984 Sep;64(1):92-103. doi: 10.1007/BF00377550.

PMID:
28311645
16.

Possible prostaglandin-mediated effect of diethylcarbamazine on rat uterine contractility.

Joseph CA, Dixon PA.

J Pharm Pharmacol. 1984 Apr;36(4):281-2.

PMID:
6144785
17.

Evolutionary trend in the metabolic oxidation of chlorpromazine.

Dixon PA.

Comp Biochem Physiol C. 1984;77(1):135-7.

PMID:
6141867
18.

Learned helplessness in the gerbil?

Brown GE, Dixon PA.

J Comp Psychol. 1983 Mar;97(1):90-2.

PMID:
6683614
19.

Effect of drug pretreatment on the metabolic oxidation of chlorpromazine in rat.

Oforah E, Dixon PA.

Pharmacology. 1983;27(3):176-9.

PMID:
6622517
20.

Sulphation and diglucuronidation as constraints to enterohepatic circulation of dichlorophen in rats.

Dixon PA.

J Pharm Pharmacol. 1982 Sep;34(9):596-7. No abstract available.

PMID:
6127389
21.

Predictive indices for chlorpromazine therapy in schizophrenics.

Dixon PA, Oforah E, Makanjuola R.

Br J Clin Pharmacol. 1982 Aug;14(2):273-7.

22.
23.

Analysis of in vivo results of cyclophosphamide-induced chromosomal damage in mammals from sensitivity and statistical aspects.

Mitchell ID, Dixon PA, White DJ.

J Toxicol Environ Health. 1981 Mar-Apr;7(3-4):585-92.

PMID:
7288904
24.

Mutagenicity of antibiotics in microbial assays. Problems of evaluation.

Mitchell I deG, Dixon PA, Gilbert PJ, White DJ.

Mutat Res. 1980 Oct;79(2):91-105.

PMID:
7001228
25.

Species variation in the metabolism of 1-naphthylacetylglycylglycylglycine.

Dixon PA.

Eur J Drug Metab Pharmacokinet. 1980;5(2):65-8.

PMID:
7398678
26.

The metabolism of 2-naphthylacetic acid in cat and rhesus monkey.

Dixon PA.

West Afr J Pharmacol Drug Res. 1979;5(1):93-4. No abstract available.

PMID:
555134
27.

Studies on the metabolism of arylacetic acids. 5. The metabolic fate of 2-naphthylacetic acid in the rat, rabbit and ferret.

Emudianughe TS, Caldwell J, Dixon PA, Smith RL.

Xenobiotica. 1978 Sep;8(9):525-34. No abstract available.

PMID:
695696
28.

Metabolism of arylacetic acids. 4. Physico-chemical, structural and biological factors influencing the pattern of conjugation.

Dixon PA, Caldwell J, Smith RL.

Xenobiotica. 1977 Dec;7(12):727-36. No abstract available.

PMID:
602247
29.
30.

Metabolism of arylacetic acids. 2. The fate of [14C]hydratropic acid and its variation with species.

Dixon PA, Caldwell J, Smith RL.

Xenobiotica. 1977 Nov;7(11):707-15.

PMID:
412331
31.
32.

Extra-mural experience for undergraduate dental students.

Holloway PJ, Dixon PA.

Br Dent J. 1977 Sep 6;143(5):146-50. No abstract available.

PMID:
268966
33.

Possible structure-induced shift from amino acid to glucuronic acid conjugation of arylacetic acids in the cat [proceedings].

Dixon PA.

West Afr J Pharmacol Drug Res. 1977 Jun;4(1):57P-59P. No abstract available.

PMID:
602187
34.

Influence of chemical structure on the pattern of conjugation in vivo and in vitro of some arylacetic acids in the rat.

Dixon PA, Caldwell J, Woods CJ, Smith RL.

Biochem Soc Trans. 1976;4(1):143-5. No abstract available.

PMID:
1001622
35.

Can ideals be preserved?

Dixon PA.

Am J Nurs. 1966 Jul;66(7):1600. No abstract available.

PMID:
5177350
36.

Cytological studies of the myxomycete Ceratiomyxa fruticulosa.

Sansome ER, Dixon PA.

Arch Mikrobiol. 1965 Sep 6;52(1):1-9. No abstract available.

PMID:
5895105

Supplemental Content

Loading ...
Support Center